Usana Health Sciences (NYSE:USNA) reported quarterly earnings results on February 17, 2026 that exceeded analyst expectations.
The Consumer Defensive company reported earnings per share of $0.60, beating the consensus estimate of $0.41 by $0.19 per share. Revenue came in at $226.2M, beating the estimate of $226.0M.
Usana Health Sciences's stock moved following the earnings release. The stock currently trades at $19.75 with a market capitalization of $374.7M.
